I 3 Pharmaceuticals
Warminster, US · Delaware LLC
Founders & leadership
RK
Ram Kishan KallurNamed on SEC filing
JV
Jayantilal V. DhadukNamed on SEC filing
DB
Dhirubhai BhagatNamed on SEC filing
DS
Douglas S. HamiltonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$16M disclosed across 1 round · 2022
▶$16MraisedMay 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$16MraisedMay 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ram Kishan KallurExecutive Officer, Director
- Jayantilal V. DhadukExecutive Officer, Director
- Dhirubhai BhagatExecutive Officer, Director
- Douglas S. HamiltonExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has I 3 Pharmaceuticals raised?
- I 3 Pharmaceuticals has disclosed $16M raised across 1 round.
- Where is I 3 Pharmaceuticals headquartered?
- I 3 Pharmaceuticals is headquartered in Warminster, US.